Blog 8 min read

Medical Devices 101 | Your Questions | October 2024

Oct 30, 2024 Medical Devices 101 | Your Questions | October 2024

Medical devices face a unique regulatory landscape that has been increasingly complicated by several factors in recent years.

The demand for more sustainable technology is being driven by both consumer demand and legislators, leading to regulatory implications. Global events such as Brexit and COVID-19 have also created unprecedented challenges.

As devices become increasingly integrated with artificial intelligence and an internet connection, new cybersecurity and data protection legislation is racing to keep up.

And on top of all this, the new regulatory framework for IVDR and proposed amendments for the registration, and inspection of medical devices under MDR means staying ahead is more critical than ever.

In our Medical Devices 101 series, we gather some of the most interesting recent inquiries from Compliance & Risks customers regarding medical device regulatory updates globally.

Article 8 of South Korea Enforcement Ordinance on the Recycling of Electrical and Electronic Equipment and Vehicles Draft Notice No. 2024-605 states that the exemption applies to “Electrical and electronic products corresponding to medical devices manufactured or imported by a person who has obtained a manufacturing or import business license pursuant to Article 6 or Article 15 of the Medical Devices Act.”

This draft amendment proposes to change the wording in this exemption to:

“Medical devices expected to be infectious as prescribed by the Minister of Environment and announced”. The Minister will determine the list of products that fall under this exemption through an announcement. Similar wording is proposed to be added as an exemption from Article 14 regarding electrical and electronic products subject to collection, transfer, and recycling obligations.

Japan has not enacted mandatory cybersecurity requirements for products but they are developing a voluntary cybersecurity certifications scheme for Internet of Things (IoT) devices. Please refer to Japan’s IoT Product Security Conformity Assessment Scheme, Policy, August 2024. This Scheme applies to IoT devices that have the ability to send and receive data using Internet Protocol (IP), including devices that can be connected to the Internet or a network.  However, it will not cover general-purpose IT products such as PCs, tablets, smartphones and etc. The Scheme will initially be operated as a voluntary scheme. By making this mandatory in the future, IoT product vendors will be given incentives to acquire labels.

In relation to medical devices registration, please refer to Japan’s Standards for Medical Devices under Article 41 (3) of Pharmaceutical Affairs Act, Notice No. 122, 2005  Amendment on cybersecurity of medical devices Notice No. 67, 2023″. This added Clause 3 on cybersecurity requirements to Article 12 of the Essential Principles criteria. Medical devices using programs are now required to ensure safety and basic performance by implementing risk management throughout the medical device software life cycle. In addition, medical devices connected to other IT devices and medical devices connected to the Internet are now required to comply with JIS T 81001-5-1 to reduce cybersecurity risks to acceptable levels.

Decree 2022-748 aims to enhance sustainability and reduce waste in various sectors, particularly focusing on product labeling and consumer information regarding sustainability and recyclability. It focuses on products meant for private households (B2C) rather than for professionals.

Stay Compliant With Global Medical Device Regulations:

Catch up on our medical device updates with your coffee here:

Medical Devices 101: Have you got a Medical Device related query?

Many of the Medical Devices 101 questions were submitted and answers were conveyed by Compliance & Risks customers via the “Ask Our Experts” button in C2P

Clients use AOE to ask about the latest proposed, enacted, and amended regulations and mandatory standards applicable to their products and geographies of interest. 

When AOE questions can be answered in 30 minutes or less, Compliance & Risks’ subject matter experts answer them at no charge!

To learn more about C2P and how Compliance & Risks SMEs can help you with your questions, contact us today.

Meet our Experts

Global Regulatory Compliance Team

Our team of experts will elevate your strategic edge by addressing questions about laws and regulations. Fluent in almost 30 languages and backed by an extensive database of 90,000+ sources, our experts bring unparalleled knowledge to the table. Moreover, our expert team is dedicated to educating your organization, fostering better engagement, and ensuring your compliance and risk management strategies are second to none. With our team of seasoned professionals by your side, you’ll gain a competitive edge in navigating the complex landscape of compliance management, gaining deeper insights and valuable guidance.